Feb 09, 2017 13:02 pm UTC| Business
Hancock, MD, Feb. 09, 2017 -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the Company), a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, augments the advisory...
Feb 09, 2017 13:02 pm UTC| Business
Hancock, MD, Feb. 09, 2017 -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the Company), a developer of a new generation of high potency veterinary cancer medications and nutraceuticals for pets, augments the advisory...
Ekso Bionics® Launches EksoPulse Cloud-Based Analytics
Feb 09, 2017 13:02 pm UTC| Business
RICHMOND, Calif., Feb. 09, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announcedthe worldwide launch of EksoPulse, an advanced cloud-based information technology platform that...
Ekso Bionics® Launches EksoPulse Cloud-Based Analytics
Feb 09, 2017 13:02 pm UTC| Business
RICHMOND, Calif., Feb. 09, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announcedthe worldwide launch of EksoPulse, an advanced cloud-based information technology platform that...
Ekso Bionics® Launches EksoPulse Cloud-Based Analytics
Feb 09, 2017 13:02 pm UTC| Business
RICHMOND, Calif., Feb. 09, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announcedthe worldwide launch of EksoPulse, an advanced cloud-based information technology platform that...
Feb 09, 2017 13:02 pm UTC| Business
NEW YORK, Feb. 09, 2017 -- Ovid Therapeutics, a privately held biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, today announced it has...
Feb 09, 2017 13:02 pm UTC| Business
NEW YORK, Feb. 09, 2017 -- Ovid Therapeutics, a privately held biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, today announced it has...